BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26708225)

  • 21. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions.
    Seiffert M; Schnabel R; Conradi L; Diemert P; Schirmer J; Koschyk D; Linder M; Kersten JF; Grosser A; Wilde S; Blankenberg S; Reichenspurner H; Baldus S; Treede H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):640-52. PubMed ID: 23172652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?
    Vavuranakis M; Kalogeras K; Vrachatis D; Kariori M; Voudris V; Aznaouridis K; Moldovan C; Vaina S; Lazaros G; Masoura K; Thomopoulou S; Stefanadis C
    Catheter Cardiovasc Interv; 2013 May; 81(6):1061-6. PubMed ID: 23197467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suture-mediated arterial access site closure after transfemoral aortic valve implantation.
    Kahlert P; Al-Rashid F; Plicht B; Konorza T; Neumann T; Thielmann M; Wendt D; Erbel R; Eggebrecht H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):E139-50. PubMed ID: 22553193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
    Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
    Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfemoral transcatheter aortic valve insertion-related intraoperative morbidity: Implications of the minimalist approach.
    Greason KL; Pochettino A; Sandhu GS; King KS; Holmes DR
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1026-9. PubMed ID: 26704061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfemoral versus Transapical Aortic Implantation for Aortic Stenosis Based on No Significant Difference in Logistic EuroSCORE: A Meta-Analysis.
    Liu Z; He R; Wu C; Xia Y
    Thorac Cardiovasc Surg; 2016 Aug; 64(5):374-81. PubMed ID: 26121378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation.
    Seiffert M; Conradi L; Terstesse AC; Koschyk D; Schirmer J; Schnabel RB; Wilde S; Ojeda FM; Reichenspurner H; Blankenberg S; Schäfer U; Treede H; Diemert P
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):460-7. PubMed ID: 25292388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of Life Shift after Aortic Valve Replacement in the Era of TAVI: Single-Center Class Comparison Study Between Different Procedural Techniques.
    Blehm A; Sorokin VA; Hartman M; Wai KL; Schmitz K; Lichtenberg A
    J Heart Valve Dis; 2015 Sep; 24(5):540-53. PubMed ID: 26897832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new technique for vascular access management in transcatheter aortic valve implantation.
    Sharp AS; Michev I; Maisano F; Taramasso M; Godino C; Latib A; Denti P; Dorigo E; Giacomini A; Iaci G; Manca M; Ielasi A; Montorfano M; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):784-93. PubMed ID: 20049970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve.
    Kawashima H; Watanabe Y; Kozuma K; Nara Y; Hioki H; Kataoka A; Yamamoto M; Takagi K; Araki M; Tada N; Shirai S; Yamanaka F; Hayashida K
    EuroIntervention; 2017 Mar; 12(16):1954-1961. PubMed ID: 27746402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications.
    Toggweiler S; Leipsic J; Binder RK; Freeman M; Barbanti M; Heijmen RH; Wood DA; Webb JG
    JACC Cardiovasc Interv; 2013 Aug; 6(8):767-76. PubMed ID: 23968697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.
    Buchanan GL; Chieffo A; Montorfano M; Maccagni D; Maisano F; Latib A; Covello RD; Grimaldi A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):579-83. PubMed ID: 22511470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club.
    Cortese B; Rigattieri S; Aranzulla TC; Russo F; Latib A; Burzotta F; Agostoni P; Ielasi A; Tarantino F; Sticchi A; Di Palma G; de Benedictis M; Trani C; Boccaletti R; Miccoli R; Valsecchi O; Colombo A
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):97-102. PubMed ID: 28463463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and Clinical Impact of Stroke Complicating Transcatheter Aortic Valve Implantation: Results From the German TAVI Registry.
    Werner N; Zeymer U; Schneider S; Bauer T; Gerckens U; Linke A; Hamm C; Sievert H; Eggebrecht H; Zahn R;
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):644-653. PubMed ID: 27258944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transaxillary versus transaortic approach for transcatheter aortic valve implantation with CoreValve Revalving System: insights from multicenter experience.
    Fiorina C; Bruschi G; Testa L; DE Carlo M; DE Marco F; Coletti G; Bonardelli S; Adamo M; Curello S; Scioti G; Panisi P; Bedogni F; Petronio AS; Ettori F
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):747-754. PubMed ID: 27701369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.